http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450083-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D225-06
filingDate 2013-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103450083-B
titleOfInvention Geldanamycin derivant and its production and use
abstract The present invention relates to the new geldanamycin analog derivative of a class, prepare the method for this compounds, and this compounds is for the preparation of the purposes of the cell killing agent of cell killing activity, inhibition of cell proliferation and antitumor drug.
priorityDate 2013-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102731401-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73851534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415854234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6505803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515199
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467370445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467374500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465973398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448569415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73554183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21681640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467787400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467787438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465617266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419724168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89952096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393375
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163880946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408904950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462122
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431304840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68534604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10553
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452192324

Total number of triples: 63.